4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-039637
Chief Financial Officer sold 20,000 shares at an average $36.33 ($726,519)
- Chief Financial Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cohen Chad M · Chief Financial Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-08 | Exercise or conversion : show line 1 in the form | +10,000 | $6.55 | $65,500 | 31,604 | D |
| 2021-06-08 | Sale : show line 2 in the form | −8,401 | $36.90 | $309,997 | 23,203 | D |
| 2021-06-08 | Sale : show line 3 in the form | −1,599 | $37.85 | $60,522 | 21,604 | D |
| 2021-06-09 | Exercise or conversion : show line 4 in the form | +10,000 | $6.55 | $65,500 | 31,604 | D |
| 2021-06-09 | Sale : show line 5 in the form | −10,000 | $35.60 | $356,000 | 21,604 | D |
| Open-market sales · 20,000 sh · avg $36.33 · $726,519 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-08 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −10,000 | 120,000 | D |
| 2021-06-09 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −10,000 | 110,000 | D |
Loading xslF345X03/doc4.xml…